四磨汤口服液用于慢性胃肠疾病治疗及腹部手术后肠胃功能康复的专家共识

Expert Consensus on Treatment of Chronic Gastrointestinal Diseases and Gastrointestinal Disorders after Abdominal Operation by Simotang Oral Liquid(四磨汤口服液)

四磨汤口服液成方收录于明代《痘疹金镜录》,具有顺气降逆、消积止痛的功效,临床常用于中老年气滞、食积证,以及腹部手术后促进肠胃功能的恢复。为进一步规范和指导四磨汤口服液的临床应用,经中华中医药学会立项,由中国中医科学院西苑医院脾胃病研究所牵头,承担《四磨汤口服液用于慢性胃肠疾病治疗及腹部手术后肠胃功能康复的专家共识》的制定工作,共识研究工作于2018年8月启动,于2020年7月由中华中医药学会正式发布。共识从总论、内科、外科及安全性四个方面就四磨汤口服液临床应用中存在的问题进行说明,希望对临床合理使用四磨汤口服液提供一定的参考。

Simotang Oral Liquid(四磨汤口服液) was recorded in Douzhen Jinjinglu in Ming Dynasty, and it was used in patients with syndrome of Qi-stagnation and food retention of mid-aged and elderly people and gastrointestinal dysfunction after abdominal surgery, with its effect of regulating and descending adverse Qi, eliminating food retention and relieving pain. In order to further standardize and guide the clinical application of Simotang Oral Liquid, the project of making Expert Consensus on Treatment of Chronic Gastrointestinal Diseases and Gastrointestinal Disorders after Abdominal Operation by Simotang Oral Liquid was approved by China Association of Chinese Medicine and developed by a special group with Institute of Spleen-stomach Disease, Xiyuan Hospital, China Academy of Chinese Medical Sciences as its head. This work was launched in August 2018 and ended in July 2020 with its publication by China Association of Chinese Medicine. Details of four parts as general descriptions, internal medicine, surgery and safety were described in this consensus, with the hope to provide references for clinical rational use of Simotang Oral Liquid.